Skyepharma PLC 07 June 2016 Skyepharma signs exclusive agreement to access Lucideon's abuse deterrent drug delivery technology First product...
JPMorgan Asset Management 07 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...
Peel Hunt LLP 07 June 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING...
JPMorgan Securities Plc 07 June 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS...
Nplus1 Singer Capital Markets Ltd 07 June 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Legal & General Investment Mgmnt Ld 06 June 2016 FORM 8.3 DEALING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
Syquant Capital 06 June 2016 Table FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...
Syquant Capital 06 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
Schroders PLC 06 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
ODDO Meriten Asset Management 06 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...
State Street Global Advisors 06 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...
JPMorgan Asset Management 06 June 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...
Peel Hunt LLP 06 June 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.